Key result
LMNA R482W mutation is linked to early, prominent dyslipidemia in pediatric patients.
Why the study?
Mutations in the LMNA gene cause familial partial lipodystrophy characterized by metabolic abnormalities including hypertriglyceridemia and insulin resistance, but detailed lipoprotein characteristics in affected families are not well described.
Case Report
Dyslipemia is an early and prominent feature in familial partial lipodystrophy caused by the R482W mutation in the LMNA gene, presenting even in childhood.
Answers are grounded in this paper and cite their sources.
Supports early lipid screening in LMNA R482W families; leaves open impact on cardiovascular outcomes.
Lipatrophic diabetes, also referred to as familial partial lipodystrophy, is a rare disease that is metabolically characterized by hypertriglyceridemia and insulin resistance. Affected patients typically present with regional loss of body fat and muscular hypertrophic appearance. Variable symptoms may comprise pancreatitis and/or eruptive xanthomas due to severe hypertriglyceridemia, acanthosis nigricans, polycystic ovaria, and carpal tunnel syndrome. Mutations within the LMNA gene on chromosome 1q21.2 were recently reported to result in the phenotype of familial partial lipodystrophy. The genetic trait is autosomal dominant. We identified a family with partial lipodystrophy carrying the R482W (Arg482Trp) missense mutation within LMNA. Here we present the lipoprotein characteristics in this family in detail. Clinically, the loss of sc fat and muscular hypertrophy especially of the lower extremities started as early as in childhood. Acanthosis and severe hypertriglyceridemia developed later in life, followed by diabetes. The characterization of the lipoprotein subfractions revealed that affected children present with hyperlipidemia. The presence and severity of hyperlipidemia seem to be influenced by age, apolipoprotein E genotype, and the coexistence of diabetes mellitus. In conclusion, dyslipemia is an early and prominent feature in the presented lipodystrophic family carrying the R482W mutation within LMNA.
No takes yet. Share an insight, caveat, or question.
Hannes Schmidt (2001) conducted a case report in Familial partial lipodystrophy. R482W mutation in the LMNA gene was evaluated on Lipoprotein characteristics and clinical presentation. The R482W mutation in the LMNA gene was associated with early and prominent dyslipemia, with affected children presenting with hyperlipidemia.
Synapse has enriched 10 related papers. Consider them for comparative context: